Contact Information

For more information on the Rare Tumors Initiative or to become a member please contact:

Karlyne Reilly, Ph.D. Director, RTI and Head, Genetic Modifiers of Tumorigenesis Section, POB, CCR, NCI

• • 301-846-7518
  • reillyk@mail.nih.gov

Brigitte Widemann, M.D. Head, Pharmacology and Experimental Therapeutics Section, CCR, NCI

• • 301-496-7387
  • widemanb@nih.gov

Abby Sandler, Ph.D. Special Assistant to the Director, Rare Tumors Initiative, OD, CCR, NCI

• • 301-496-9983
  • sandlera@mail.nih.gov